Trump Gives Generic Drug Imports a Tariff-Free Pass Until August 2028
US President Donald Trump announced the final phase of his pharmaceutical tariff plan on Tuesday. Under the plan, imported generic medicines will remain exempt from duties until August 1, 2028. The temporary reprieve is significant for India, a major supplier of generic drugs to the United States. This window gives Indian pharmaceutical companies time to remain price-competitive in the American market before any tariffs take effect.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.


Discussion (0)
Log in to join the discussion and vote.
Log in